25th Mar 2022 20:39
4basebio PLC - Heidelberg, Germany-based life sciences company - On Wednesday expands its synthetic DNA product offering with the addition of its opDNA product and its oeDNA product. Chief Executive Heikki Lanckriet says: "The development of our DNA product range over the past twelve months underscores the flexibility of our technology and our ability to customise DNA for particular uses. We are able to modify our DNA constructs for an individual customer's specific application."
Current stock price: 500.00 pence
12-month change: up 47%
By Heather Rydings; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
4basebio Plc